Bob Flaherty Rides Again! Welcome to our 46th Flaherty Financial Newsletter.

(Updated April 22, 2015)

Notice Regarding Forward-Looking Statements This presentation contains a summary of statements from Bob Flaherty’s Financial News Newsletter and includes certain forward-looking statements regarding Stevia First Corp.’s (the “Company”) strategy and growth prospects as well as the drivers of the Company’s business which are subject to risks and uncertainties. The forward-looking statements in this presentation are subject to risks and uncertainties and include statements regarding our financial position, business strategy, and other plans and objectives for future operations, as well as any other statements which are not based on historical facts. Although we believe that these statements are based on reasonable assumptions, they are subject to numerous factors, risks, and uncertainties that could cause actual outcomes and result to be materially different from those projected. These factors, risks, and uncertainties include the Company’s limited operating history and inability to predict future operations with any certainty. Stevia First Corp. (OTCQB: STVF) as well as any divisions, subsidiaries or affiliates does not undertake to update any forward-looking statements. This presentation does not constitute an offer to sell or the solicitation of an offer to buy securities of Stevia First Corp.

Reinventing Human Nutrition Dedicated to providing healthy mainstream solutions to

the global diabetes and obesity epidemics.

OTCQB: STVF

When others were selling blindly, our late contrarian friend Sir John Templeton used such

opportunities to find new bargains.

So in this issue we spotlight a rising star we like a lot.

Stevia First Corp. is developing a big idea!

I always enjoy writing about a new enterprise where Avtar Dhillon serves as chairman. Besides naturally wanting to

make money, each new venture must be an effort to tackle a serious unmet medical need whose solution would leave

mankind better off.

Immigrating at eight from India to Canada, Avtar became a doctor and devoted himself strictly to

family practice for nine years. Then for three years he tried part-time venture capital.

He learned that he was exceptionally good at understanding what medical people were attempting

to do. He also enjoyed bringing them the missing financial and managerial resources to realize their

goals…

…And Stevia First Corp. was born…

Making its debut at a September Rodman & Renshaw conference Stevia First Corp. (STVF-0.38)

was introduced to investors by its dynamic CEO, Robert Brooke.

As a hedge fund analyst Brooke made over 50 direct healthcare investments and had looked for a big idea to make his own

entrepreneurial mark.

He found it here in disruptive technology to help reduce our daily sugar intake and the millions suffering from its related ills

like the epidemic of diabetes 2.

Look around you! Many people are blowing up like balloons,

waddling as they walk. Did you know almost 40% of the

American population is obese and in danger of getting diabetes?

Did you know about 30% to 40% of American healthcare spending goes to help address issues closely tied to the excess consumption of sugar?

Worse, much of their sugar intake is involuntary.

The most visible culprits are the soft drink companies. But we are clueless that harmful sugar is added as a sweetener or preservative in many other food and

drink products we consume.

We are what we eat… Our unhealthy food intake is killing many of us.

The public wants alternatives to sugar but is afraid artificial sweeteners are not safe.

This dilemma has given all-natural, zero-calorie stevia an opening in the more than $58 billion sweetener

market.

The World Health Organization estimates stevia could capture as much as 20% to 30% of all dietary

sweeteners.

“Our time is now!” says Bob Brooke.

“After our recent stevia supply and distribution deal with China-based Qualipride, we became much more

than a research and development biotechnology agricultural business.”

“The next three to six months are going to be key."

The new deal should produce commercial sales this quarter with the chance of positive cash flow within

12 months.

Combine this with their: • Patent-pending enzyme enhancement process which doubles

stevia leaf yields • Plans for integrated stevia production in California • New bio-agricultural methods including an experiment to use

drones with LED spotlighting to lengthen daily growing hours. • Research on next generation products which will be even sweeter

than the current most popular stevia product Reb A.

And Stevia First Corp. could turn into a very important player.

OTCQB: STVF

Stevia First is poised to become a premier global stevia supplier - and the only producer in North

America.

Anything can happen. The highly competitive soft drink space is dominated

by huge powerful multinationals. Coca-Cola has already launched successful reduced sugar products

using stevia.

Some strategic partnerships with Stevia First Corp. could result.

So far, Stevia First's transition from R & D into going commercial is ahead of schedule.

And the stock price is right..!

At $0.35 recently shares are down 34% from their 12 month high of $0.58 and 88% from the initial craze

when shares reached $3.28 in March 2012.

OTCQB: STVF

Yet the following CEO Presentation Profile shows that Stevia First is a much bigger, better and stronger company today than when its stock was so much

higher.

So join us for our initial story on Stevia First as it transitions from a brilliant R & D concept into a viable

commercial company.

I believe Stevia First has all the elements to become a big stock winner. Read along and see if you agree.

-RJF

Sweet Ideas at Stevia First! CEO Bob Brooke is transitioning Stevia First to play an important role in reducing harmful daily sugar intake in the fight against the twin epidemics of obesity and

diabetes 2.

By Robert J. and Brian D. Flaherty

"The trend upon which we are capitalizing upon is sugar reduction. This is something we are confident is

imminent and an undeniable trend."

Robert Brooke, CEO Stevia First Corp.

According to a comprehensive Credit Suisse report Sugar at

a crossroads "...30% to 40% of healthcare expenditures in the USA go to help address

issues that are closely tied to excess consumption of sugar."

Key conclusion: "The most likely outcome over the next 5-10 years will be a significant reduction in sugar consumption and a marked increase in the role played by high-intensity natural sweeteners in foods and beverages."

These have become poster boys for what is wrong with our food intake. Global public health warnings

are everywhere.

In California for example ChooseHealthLA.com's provocative poster asks, "You wouldn't eat 22 packs

of sugar. Why are you drinking them?"

That's a pretty big question.

The World Health Organization came out with guidelines cutting daily sugar intake guidance to less

than a single 12-oz sugary drink each day or 5% of your calories.

So that's the problem for the major beverage makers.

But artificial sweeteners aren't safe or are only somewhat safe.

So what to do?

The answer is stevia.

The all-natural, zero- calorie, high-intensity sweetener used for hundreds of years in South

America.

That's why there is a major growth opportunity for stevia as a safe, natural sweetener in soft drinks and

as a replacement of harmful sugar as a food additive.

But for that food revolution to happen on a massive scale the

supply of stevia must be increased dramatically.

It must also be affordable and reliable. Also stevia's quality and consistency must be kept up for the

sweet taste of success in current and next generation products.

What we're aiming to do is to supply the major customers of stevia today.

There have already been breakthrough products with stevia. Coca-Cola Company's

Water Vitamin Zero scored over $100 million of sales in its first year on the market.

Truvia, a table top sweetener from Cargill, became the number two sugar substitute in

the U.S. in only its second year.

"These are now household names.

So stevia really works!

The major beverage makers like Coca-Cola and others who use sweeteners need a more reliable

supply.

They need a larger supply with more capacity.

So this is our challenge to meet as a company.

…And we’re doing it..!

We’re pioneering an enzyme enhancement

process which doubles high purity

stevia end-product…

Using a process we developed internally, we have a pilot production program and we are scaling it, working to industrialize it to generate up to 200

metric tons annual per year.

Stevia Reb A extract sells for $100,000 per metric ton or more.

By using drones shining LED light to lengthen the growing day we have a unique application where if we

delay stevia plant flowering we can greatly increase the amount of stevia in the leaf by three to five fold

from the same amount of acreage.

The company is aiming to lead, not follow.

OTCQB: STVF

Stevia First has patents or patent applications related to production of stevia through

biosynthesis…

…And is developing novel agricultural production methods using drone technology and LED

photoperiod interruption.

We are a very R & D invested business.

Now let's talk about our recent deal with Qualipride.

It’s a global exclusive agreement with China - based Qualipride, one of the

world’s major stevia suppliers.

We now have access to a supply chain that rivals anyone within the industry

today.

And that gets us a LOT of attention.

Our agreement with Qualipride provide exclusive terms for Stevia First to take over stevia distribution business with access through partners to a supply

chain that can support more than 1,000 metric tons of annual stevia production capacity of annual high-

purity Reb A.

That represents a big chunk of the stevia industry as it exists today.

Their inventories may be more than 100 tons of high purity stevia extract in stock and available

immediately…

…And as their exclusive distributor, we expect to see margins from resale and with enough supply to

support our own needs.

Now with exclusive rights to modern stevia extraction and refining technologies outside of China, Stevia First

plans to begin construction of the first vertically -integrated North American stevia production facilities

in California's Central Valley

Controlling all aspects (Stevia seed, leaf, extract, refining and sales) can secure us preferential pricing, and guarantee to our customers delivery of stevia on

time at the right price year after year.

The Qualipride group has been doing this for over 15 years. Their supply chain works with family farms in China. The first product we're rolling out is a high-purity Reb A using our own enzyme enhancement.

The bigger picture is with very reasonable and conservative assumptions for margins and sales we could reach cash flow positive in 12 months even

while investing heavily in long term R & D.

This is a supply chain with a lot of room for growth.

In March 2015, we also announced a technology collaboration that aims to transform sugary beverage consumption through bottling facilities in Mexico and

Latin America

(Mexico leads the world in sugar-sweetened beverage consumption and type 2 diabetes is the leading cause

of mortality)

We recently added to our team process engineering expertise that has been deeply integrated into Coca-Cola’s supply chain of bottling facilities in Mexico for

more than 20 years.

In our U.S. expansion we are targeting a minimum production of 200 metric tons of high purity stevia

from our California enzyme enhancement.

We could easily have access to 500 to 1,000 metric tons of supply.

For comparison the leading stevia supplier, Malaysia-based Purecircle (PURE.L), has a valuation of more

than US$1.0 billion with a fully invested supply chain capable of delivering 2,800 metric tons of high purity

stevia which can support sales of $250 to $300 million annual sales.

Our supply chain today rivals really anyone within the industry.

It is only a matter of time before we start to deliver

on contracts and start to make our footprint.

How do we realize value for shareholders?

We keep our capital structure clean. We have about 72.9 million shares, no significant debt or preferred

stock or significant overhang.

OTCQB: STVF

In terms of cash we have a very modest ‘burn rate’ and we have always done a good job of striking

terms for any growth financing we do.

On Oct. 1 Stevia announced raising over $1.4 million from existing institutional investors to keep up its

momentum.

We are a small company today. We are an ag-biotech with a recent total stock market cap of around

$25 million.

We are working with identified demand from companies like Coca-Cola, who spend by themselves

$6 billion a year on sweeteners.

Carve out a little bit of value for these guys and we will get rewarded.

And that is just what we are doing.

Truly, Reinventing Human Nutrition Find out more at http://www.steviafirst.com

OTCQB: STVF

Disclaimer: This Flaherty Financial News Newsletter contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks and uncertainties, and actual circumstances, events or results may differ materially from those projected. We caution readers not to place undue reliance on any forward-looking statements and to supplement this newsletter with specific company SEC filings and their own research. Please be aware that there is risk in every company stock that you buy. Coverage or other mention of a stock or fund in this newsletter is neither an offer nor solicitation to buy or sell any securities mentioned. We are not investment dealers or investor advisers registered with the SEC or State Security Authorities. We do not guarantee all the information in this newsletter is correct or will be updated. Remember some errors are inevitable. Reproduction without written permission is forbidden. Flaherty Financial News Inc. received $6,000 in cash from Stevia First Corp. for editorial writing and online distribution of this newsletter beyond our regular core readers. Our own policy forbids editorial from buying or selling a featured stock until this issue is out at least ten business days after its issue date, which in this case would be April 27, 2015. In cases where a report or profile is subsidized, readers should consider such subsidized articles as paid advertorials and understand that sponsored material will not be as objective as non-sponsored editorial. As Flaherty Financial News editor I always reserve "Final Copy Responsibility" on what to include and what to leave out of every issue. The buck stops here. We have tried to be objective, but may have failed. We are not security analysts or stockbrokers engaged in buying or selling, but financial journalists with all the many failings of that profession. You readers must decide the merits of each investment yourself and whether to invest. - Bob Flaherty, Editor Flaherty Financial News Inc. (FFN) and its newsletters Flaherty Financial News and Flaherty Special Situations are not registered as broker dealers or investment advisers with the U.S. Securities and Exchange Commission or any state securities authority. Our newsletters and their information and content providers make no representations or warranties of any kind in connection with the subject matter, performance or suitability of the information contained in the publications for any purpose and are not liable for the timeliness, accuracy or completeness of the information. The information is provided for general information purposes and is not a substitute for obtaining professional advice from a qualified person or entity familiar with your personal circumstances. Please seek the help and advice of professionals as appropriate regarding the evaluations of any specific security, report, opinion, advice or other content. FFN is not responsible for trades placed by recipients. All opinions expressed, information and data provided are subject to change without notice. FFN, its officers and its employees may have positions in and may from time to time make purchases or sales of the securities discussed or mentioned by FFN. (However, we will avoid front running and the buying or selling of any security about to be discussed until ten business days after our particular report is released to the public.) FFN shall have no liability for any newsletter that is lost, intercepted or not received in a timely manner, or not received at all, for any reason.-RJF